Crinetics Pharmaceuticals, Inc.
CRNX
$84.70
$0.260.31%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.79% | 1.35% | -24.09% | 26.62% | 38.64% |
| Total Receivables | -- | -22.30% | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 13.43% | 326.09% | -14.31% | 366.72% | 373.85% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -73.40% | -80.28% |
| Total Current Assets | 2.23% | 2.43% | -23.78% | 27.77% | 39.15% |
|
|
|||||
| Total Current Assets | 2.23% | 2.43% | -23.78% | 27.77% | 39.15% |
| Net Property, Plant & Equipment | -7.76% | -3.68% | -1.42% | -0.81% | -1.20% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 61.02% | 97.85% | 482.17% | 961.95% | 947.80% |
| Total Assets | 2.51% | 2.94% | -21.49% | 27.59% | 37.84% |
|
|
|||||
| Total Accounts Payable | 16.98% | 30.86% | 286.31% | 23.69% | 27.65% |
| Total Accrued Expenses | 20.30% | 31.32% | 23.00% | 52.64% | 36.85% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -0.38% | -5.04% | -9.27% | -13.11% | -11.22% |
| Total Finance Division Other Current Liabilities | -12.34% | -42.38% | -43.24% | -14.75% | -26.17% |
| Total Other Current Liabilities | -12.34% | -42.38% | -43.24% | -14.75% | -26.17% |
| Total Current Liabilities | 16.84% | 24.04% | 42.54% | 38.45% | 25.78% |
|
|
|||||
| Total Current Liabilities | 16.84% | 24.04% | 42.54% | 38.45% | 25.78% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -6.28% | -5.96% | -5.65% | -5.37% | -5.55% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 48.59% | 36.05% | 27.42% | 22.75% | 39.89% |
| Total Liabilities | 10.06% | 12.44% | 22.21% | 18.65% | 12.67% |
|
|
|||||
| Common Stock & APIC | 22.61% | 22.92% | 5.79% | 38.90% | 43.61% |
| Retained Earnings | -43.07% | -47.33% | -48.87% | -48.55% | -46.54% |
| Treasury Stock & Other | -383.04% | -214.19% | 82.04% | 2.16% | 894.21% |
| Total Common Equity | 1.74% | 2.12% | -25.11% | 28.71% | 41.02% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.74% | 2.12% | -25.11% | 28.71% | 41.02% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.74% | 2.12% | -25.11% | 28.71% | 41.02% |
|
|
|||||